# About the Study

The Heart Biomarker Evaluation in Apnea Treatment (HeartBEAT) is a multi-center Phase II randomized controlled trial that evaluates the effects of supplemental nocturnal oxygen or Positive Airway Pressure (PAP) therapy, compared to optimal medical preventive therapy, over a 3 month intervention period in patients with cardiovascular disease (CVD) or CVD risk factors and moderate to severe obstructive sleep apnea (Apnea-Hypopnea Index 15 to 50). The study's primary outcome is 24 hour blood pressure profile.

Read more about HeartBEAT at [ClinicalTrials.gov (NCT01086800)](http://clinicaltrials.gov/show/NCT01086800).

## Citation

When citing this dataset please use:

1. Dean, D. A., Goldberger, A. L., Mueller, R., Kim, M., Rueschman, M., Mobley, D., Sahoo, S. S., Jayapandian, C. P., Cui, L., Morrical, M. G., Surovec, S., Zhang, G. Q., & Redline, S. (2016). Scaling Up Scientific Discovery in Sleep Medicine: The National Sleep Research Resource. *Sleep*. Advance online publication. pii: sp-00021-15

## Dataset Download

<a href=":files_path:/datasets" class="btn btn-success btn-lg">Download Full Dataset</a> 1.7 MB

Read more in the [Dataset Introduction](:pages_path:/dataset-introduction.md).

## Protocols and Manuals

- [HeartBEAT Manual of Procedures](:pages_path:/manuals/manuals-toc.md)
- [HeartBEAT Forms](:files_path:/forms)

## Equipment
- [Montage and Sampling Rate Information](:pages_path:/equipment/montage-and-sampling-rate-information.md)

## Recent Changes

- Find a complete list of changes in the [CHANGELOG.md](:pages_path:/CHANGELOG.md)

## Publication Links

- [CPAP versus Oxygen in Obstructive Sleep Apnea](http://www.nejm.org/doi/full/10.1056/NEJMoa1306766)
